Zhejiang Starry Pharmaceutical ,Ltd. Inventory

Zhejiang Starry Pharmaceutical ,Ltd. posts a inventory of $1.1B as of June 2026. That compares with $950M in the prior-year period — up 20.3% year over year. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, Zhejiang Starry Pharmaceutical ,Ltd.'s inventory was $950M. The latest reading is $1.1B — a 20.3% year-over-year increase (period ending June 2026). Use the history and growth charts on this page for a longer lookback.

Inventory is one piece of Zhejiang Starry Pharmaceutical ,Ltd.'s financial statement story. At $1.1B, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.

Context for 603520.SS's inventory usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; Zhejiang Starry Pharmaceutical ,Ltd.'s other metric pages and overview cover the third.